1O Dynamic circulating tumour DNA (ctDNA) response to neoadjuvant (NA) atezolizumab (atezo) and surgery (surg) and association with outcomes in patients (pts) with NSCLC
Mark G. Kris, Jessica M. Grindheim, Jamie E. Chaft, J.M. Lee, Bruce E. Johnson, Valerie W. Rusch, Paul A. Bunn, Harvey I. Pass, E. Schum, Jennifer W. Carlisle, M. Weyant, A. Nicholas, Ann Johnson, D. Shames, Ignacio I. Wistuba, David P. Carbone, Katja Schulze, David J. Kwiatkowski
Topics & Concepts
MedicineAtezolizumabOncologyInternal medicineNeoadjuvant therapyCancerImmunotherapyPembrolizumabBreast cancerCancer Genomics and DiagnosticsGenetic factors in colorectal cancerLung Cancer Treatments and Mutations